title: ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
authors: Department of Anesthesiology, Yale University, New Haven, CT 06520-8051, USA. adriana.oprea@yale.edu
authors: Adriana Dana
authors: AD
authors: Oprea
authors: Wanda M
authors: WM
authors: Popescu
mesh_terms: D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000379:methods; D000077144:Clopidogrel; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D019990:Perioperative Care / Q000379:methods*; D010879:Piperazines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018048:Receptors, Purinergic P2 / Q000187:drug effects / Q000502:physiology*; D058925:Receptors, Purinergic P2Y12 / Q000187:drug effects*; D013514:Surgical Procedures, Operative / Q000379:methods; D013876:Thiophenes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077486:Ticagrelor; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D018048:Receptors, Purinergic P2; D058925:Receptors, Purinergic P2Y12; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine
keywords: ADP receptor inhibitors; cangrelor; clopidogrel; perioperative period; prasugrel; ticagrelor